OBJECTIVE: To evaluate the effectiveness and long-term results of using a self-expanding metallic urethral stent (Urolumetrade mark, American Medical Systems, Minnetonka, MI, USA) to treat recurrent bulbar urethral strictures. PATIENTS AND METHODS: Between 1990 and 1999, 65 stents were placed in 60 men (mean age 45.2 years, range 20-71) with a urethral stricture (mostly caused by trauma and present for a mean of 4.3 years, range 0.16-26) and who had previously undergone different unsuccessful treatments. RESULTS: During a mean (range) follow-up of 3.8 (1-9) years the strictures in 52 of the 60 patients (87%) were treated successfully. All patients initially had postvoid dribbling incontinence, but this resolved in most within one week; 19 patients remain incontinent. CONCLUSION: The Urolume is a cost-effective alternative to other treatments for recurrent bulbar urethral strictures of whatever cause.
OBJECTIVE: To evaluate the effectiveness and long-term results of using a self-expanding metallic urethral stent (Urolumetrade mark, American Medical Systems, Minnetonka, MI, USA) to treat recurrent bulbar urethral strictures. PATIENTS AND METHODS: Between 1990 and 1999, 65 stents were placed in 60 men (mean age 45.2 years, range 20-71) with a urethral stricture (mostly caused by trauma and present for a mean of 4.3 years, range 0.16-26) and who had previously undergone different unsuccessful treatments. RESULTS: During a mean (range) follow-up of 3.8 (1-9) years the strictures in 52 of the 60 patients (87%) were treated successfully. All patients initially had postvoid dribbling incontinence, but this resolved in most within one week; 19 patients remain incontinent. CONCLUSION: The Urolume is a cost-effective alternative to other treatments for recurrent bulbar urethral strictures of whatever cause.
Authors: Melih Culha; Unsal Ozkuvanci; Seyfettin Ciftci; Ali Saribacak; Murat Ustuner; Ufuk Yavuz; Hasan Yilmaz; Levend Ozkan Journal: Int J Clin Exp Med Date: 2014-10-15